Karo Pharma AB diskutieren
Karo Pharma AB
WKN: A14YW4 / Symbol: KARO / Name: Karo Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,44 €
-0,18 %
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $27.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $37.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Raymond James from $30.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $26.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $34.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $31.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $31.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock, up previously from $46.00.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $51.00 to $58.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by Roth Mkm.
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its price target lowered by UBS Group AG from $60.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by Needham & Company LLC.
Ratings data for KARO provided by MarketBeat
Neueste Beiträge
Mizuho in Chewy Inc diskutieren